Atlas Trials

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Clinical trial NCT02582073 · COMPLETED

Trial details

NCT number
NCT02582073
Sponsor
Allergy Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Seasonal Allergic Rhinitis
Start date
2015-11-07
Primary completion
2016-05-05
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.